0001104659-24-034102.txt : 20240313 0001104659-24-034102.hdr.sgml : 20240313 20240313212155 ACCESSION NUMBER: 0001104659-24-034102 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240311 FILED AS OF DATE: 20240313 DATE AS OF CHANGE: 20240313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Griffin Jerry C CENTRAL INDEX KEY: 0001327953 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38468 FILM NUMBER: 24747702 MAIL ADDRESS: STREET 1: 887L INDUSTRIAL ROAD CITY: SAN CARLOS STATE: CA ZIP: 94070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inspire Medical Systems, Inc. CENTRAL INDEX KEY: 0001609550 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 261377674 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5500 WAYZATA BLVD STREET 2: SUITE 1600 CITY: GOLDEN VALLEY STATE: MN ZIP: 55416 BUSINESS PHONE: 763-957-5037 MAIL ADDRESS: STREET 1: 5500 WAYZATA BLVD STREET 2: SUITE 1600 CITY: GOLDEN VALLEY STATE: MN ZIP: 55416 4 1 tm248803-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-03-11 0 0001609550 Inspire Medical Systems, Inc. INSP 0001327953 Griffin Jerry C C/O INSPIRE MEDICAL SYSTEMS, INC. 5500 WAYZATA BLVD., SUITE 1600 GOLDEN VALLEY MN 55416 1 0 0 0 1 Common Stock 2024-03-11 4 M 0 1000 16 A 10298 D Common Stock 2024-03-11 4 S 0 54 198.05 D 10244 D Common Stock 2024-03-11 4 S 0 500 198.05 D 9744 D Stock Option (Right to Buy) 16 2024-03-11 4 M 0 1000 0 D 2028-05-02 Common Stock 1000 2296 D The prior Form 4 for the Reporting Person dated March 5, 2024 contained a contained a computational error in the total number of securities beneficially owned following the reported transactions. The current total reflects the accurate number of shares held by the Reporting Person. Reflects shares sold to cover taxes upon the option exercise pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The option is fully vested and exercisable. /s/ Bryan Phillips, as Attorney-in-Fact for Jerry C. Griffin 2024-03-13